Inflammatory myofibroblastic tumours of the thorax: Radiologic and clinicopathological correlation

Abstract

Context and Aims: Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal neoplasm with intermediate malignant potential. The aim of this study is to describe and compare the clinical presentation, computed tomography (CT) findings and anaplastic lymphoma kinase -1 (ALK-1) expression of IMT of the thorax in children and adults. We also sought to study the tumour behaviour after treatment on the follow-up imaging. Materials and Method: This is a retrospective observational study of 22 histopathologically proven cases of IMT in the thorax. The clinical parameters, CT findings, biopsy results, treatment received and follow-up were recorded. Statistical analysis was performed using Fisher’s exact test. Results: IMT of the thorax had diverse imaging appearances, presenting either as large invasive lung masses with or without calcifications or as smaller endobronchial lesions. Children commonly presented with long duration fever (P = 0.02) and large invasive lung masses (P = 0.026), whereas adults presented with long duration haemoptysis (P = 0.001) and endobronchial lesions or smaller lung parenchymal lesions. Calcifications were more common in children (P = 0.007). ALK-1 was positive in 40% of children and 18.2% of adults (P = 0.547). Endobronchial lesions showed a trend for ALK-1 negativity. Patients with bronchoscopic excision had local recurrence and patients with surgical wedge resection had metastatic brain lesions as compared to those with lobectomy and pneumonectomy (P = 0.0152). A patient with unresectable lung mass had malignant transformation to spindle cell sarcoma after 9.5 years. Conclusions: Thoracic IMT presents with some distinct clinical and CT findings in adults and children. The CT findings and management options have implications for prognosis. If resectable, lobectomy is a better option than wedge resection or bronchoscopic excision for preventing local recurrence and metastasis. IMT can undergo malignant transformation.

Keywords

Anaplastic lymphoma kinase-1 - inflammatory myofibroblastic tumour - thorax

Publikationsverlauf

Eingereicht: 25. Februar 2020

Angenommen: 18. Juni 2020

Artikel online veröffentlicht:
19. Juli 2021

• References

• 1 Zhu L, Li J, Liu C, Ding W, Lin F, Guo C. et al. Pulmonary inflammatory myofibroblastic tumor versus IgG4- related inflammatory pseudotumor: Differential diagnosis based on a case series. J Thorac Dis 2017; 9: 598-609
• 2 Liang W, Zhou X, Xu S, Lin S. CT manifestations of inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the urinary system. AJR Am J Roentgenol 2016; 206: 1149-55
• 3 Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC. et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363: 1727-33
• 4 Mahale A, Venugopal A, Acharya V, Kishore M, Shanmuganathan A, Dhungel K. Inflammatory myofibroblastic tumor of lung (Pseudotumor of the lung). Ind J Radiol Imag 2006; 16: 207-10
• 5 Carvalho A, Correia R, Fernandes MS, Pinheiro J, Leitão P, Padrão E. et al. Pulmonary inflammatory myofibroblastic tumor: Report of 2 cases with radiologic-pathologic correlation. Radiol Case Rep 2017; 12: 251-56
• 6 Takeda S, Onishi Y, Kawamura T, Maeda H. Clinical spectrum of pulmonary inflammatory myofibroblastic tumor. Interact Cardiovasc Thorac Sur 2008; 7: 629-33
• 7 Camela F, Gallucci M, di Palmo E, Cazzato S, Lima M, Ricci G. et al. Pulmonary inflammatory myofibroblastic tumor in children: A case report and brief review of literature. Front Pediatr 2018; 6: 35
• 8 Van den Heuvel DA, Keijsers RG, Van Es HW, Bootsma GP, de Bruin PC, Schramel FM. et al. Invasive inflammatory myofibroblastic tumor of the lung. J Thorac Oncol 2009; 4: 923-6
• 9 Ufuk F, Herek D, Karabulut N. Inflammatory myofibroblastic tumor of the lung: Unusual imaging findings of three cases. Pol J Radiol 2015; 80: 479-82
• 10 Fletcher CD, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press; 2013: 83-4
• 11 Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory myofibroblastic tumors: Current update. Radiol Clin North Am 2016; 54: 553-63
• 12 Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumour. Radiographics 2003; 23: 719-29
• 13 Jeung M, Gasser B, Gangi A, Charneau D, Ducroq X, Kessler R, Quoix E. et al. Bronchial carcinoid tumors of the thorax: Spectrum of radiologic findings. Radiographics 2002; 22: 351-65
• 14 Khan AA, El-Borai AK, Alnoaiji M. Pleuropulmonary blastoma: A case report and review of the literature. Case Rep Pathol 2014; 2014 509086
• 15 Cobanoglu N, Alicioglu B, Toker A, Galip N, Bassullu N, Dogusoy GB. Radiologic diagnosis of a type-iii pleuropulmonary blastoma. JBR–BTR 2014; 97: 353-5
• 16 Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res 2009; 37: 867-77
• 17 Siminovich M, Galluzzo L, López J, Lubieniecki F, de Davila MT. Inflammatory myofibroblastic tumor of the lung in children: Anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation. Pediatr Dev Pathol 2012; 15: 179-86
• 18 Panagiotopoulos N, Patrini D, Gvinianidze L, Woo WL, Borg E, Lawrence D. Inflammatory myofibroblastic tumour of the lung: A reactive lesion or a true neoplasm?. J Thorac Dis 2015; 7: 908-11
• 19 Pavithran K, Manoj P, Vidhyadharan G, Shanmughasundaram P. Inflammatory myofibroblastic tumor of the lung: Unusual imaging findings. World J Nucl Med 2013; 12: 126-8
• 20 Jehangir M, Jang A, Ur Rehman I, Mamoon N. Synchronous inflammatory myofibroblastic tumor in lung and brain: A case report and review of literature. Cureus 2017; 9: e1183
• 21 Marino-Enriquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJF, Fletcher CDM. et al. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 2011; 35: 135-44